<PAGE>
As filed with the Securities and Exchange Commission on August 30, 2000
REGISTRATION NO. 333-46165
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------------------
ANIKA THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)
MASSACHUSETTS 04-3145961
(State of Incorporation) (I.R.S. Employer
Identification No.)
236 WEST CUMMINGS PARK
WOBURN, MA
(718) 932-6616
(Address of Principal Executive Offices)
------------------------------------
J. MELVILLE ENGLE
CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER
ANIKA THERAPEUTICS, INC.
236 CUMMINGS PARK
WOBURN, MA
(781) 932-6616
(Name, Address and Telephone Number, Including Area Code, of Agent For Service)
------------------------------------
Copy to:
H. DAVID HENKEN, P.C.
GOODWIN, PROCTER & HOAR LLP
EXCHANGE PLACE
BOSTON, MASSACHUSETTS 02109
(617) 570-1000
================================================================================
<PAGE>
On February 12, 1998, the Registrant registered 203,700 shares of its
common stock, par value $.01 per share, for resale by Leerink, Swann, Gerrity,
Sollami, Yaffe & Wynn (the "Selling Stockholder") pursuant to a Registration
Statement on Form S-3 (File No. 333-46165) (the "Registration Statement"). As
the Registrant's obligations to the Selling Stockholder pursuant to a Stock
Purchase Agreement dated as of February 29, 1996 and a Letter Agreement dated as
of August 27, 1997 by and between the Registrant and the Selling Stockholder
have been fulfilled, the Registrant files this Post- Effective Amendment No. 1
to the Registration Statement to terminate the Registration Statement.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this
Post-Effective Amendment No. 1 to the Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Woburn, the
Commonwealth of Massachusetts, on this 29th day of August, 2000.
ANIKA THERAPEUTICS, INC.
By: /s/ J. Melville Engle
-------------------------------------
J. Melville Engle
Chairman, President and Chief Executive
Officer
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 1 to the Registration Statement has been signed
below by the following persons in the capacities and on the date indicated.
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/ J. Melville Engle Chairman, Chief Executive Officer & August 29, 2000
---------------------------------------- President (Principal Executive Officer)
J. Melville Engle
/s/ Douglas R. Potter Chief Financial Officer, Treasurer and
---------------------------------------- Clerk (Principal Financial and
Douglas R. Potter Accounting Officer) August 29, 2000
* Director August 29, 2000
----------------------------------------
Joseph L. Bower
* Director August 29, 2000
----------------------------------------
Eugene A. Davidson
* Director August 29, 2000
----------------------------------------
Samuel F. McKay
* Director August 29, 2000
----------------------------------------
Harvey S. Sadow
* Director August 29, 2000
----------------------------------------
Steven E. Wheeler
*By: /s/ J. Melville Engle August 29, 2000
------------------------------------
J. Melville Engle
Attorney-in-Fact
</TABLE>
